Cross Country Healthcare (CCRN) AI Stock Analysis

• Market Cap: $433.44M
• Dividend Yield: N/A
• Average Volume (3M): 260.58K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.05
• Revenue Growth: -24.30%
• EPS Growth: -210.27%
• Country: US
• Employees: 9,605
• Sector: Healthcare
• Sector Strength: 49
• Industry: Medical - Care Facilities
• EPS (TTM): -0.01
• Shares Outstanding: 32,761,993
• 10 Day Avg. Volume: 213,531
• 30 Day Avg. Volume: 260,583
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.80
• Enterprise Value/Revenue: 0.29
• Enterprise Value/Gross Profit: 1.46
• Enterprise Value/Ebitda: 26.98
• 1Y Price Target: $18.61
• Price Target Upside: 40.67% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 5

• Rating: 45 Neutral
• Price Target: $13.00 ▼(-1.74% Downside)

The overall stock score is primarily impacted by weak financial performance, particularly in revenue growth and cash flow management. The technical analysis is inconclusive due to missing data, and the valuation suggests potential overvaluation. The absence of earnings call and corporate events data limits further insights.

Positive Factors

Acquisition Agreement

CCRN entered into a definitive agreement to be acquired by Aya Healthcare for $615M in cash, or $18.61 per share, a 67% premium to the prior closing price.

Cost Management

The company successfully minimized costs, with SG&A down 17% year-over-year and almost no bad debt expense.

Negative Factors

Regulatory Approval Uncertainty

The transaction is expected to be completed pending regulatory approval, which is far from certain with the shares trading 32% below the offer.

Revenue Decline

Q1/25 revenue of $293.4 million came in lower than the consensus of $305.4 million, while declining -23% YOY due to the continuation of softer demand conditions across the healthcare travel staffing industry.

Cross Country Healthcare Business Overview & Revenue Model

Company Description

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

How the Company Makes Money

Cross Country Healthcare generates revenue primarily through its staffing services, which include travel nurse placements, per diem staffing, and allied health staffing. The company charges healthcare facilities a fee for each healthcare professional placed, often based on a markup on the hourly wage paid to the staff. Additionally, CCRN earns revenue through managed services provider (MSP) solutions and other workforce management services that streamline staffing processes for healthcare organizations. Significant partnerships with hospitals, healthcare systems, and other entities enhance its service offerings and contribute to consistent demand for its staffing solutions, ultimately driving its earnings.

Cross Country Healthcare Financial Statement Overview

Summary

Cross Country Healthcare faces significant challenges with declining revenues and profitability, as seen in the income statement. The balance sheet showcases moderate stability with low leverage, but declining asset levels raise concerns about liquidity. Cash flows exhibit volatility, indicating potential operational difficulties. Overall, the company must address its profitability issues to enhance financial health.

Income Statement

The company's income statement shows a concerning trend with declining revenues and profitability. The TTM data reveals negative EBIT and net income, indicating operational and profitability challenges. The gross profit margin has decreased over the years, suggesting increased cost pressures or inefficiencies.

Balance Sheet

The balance sheet exhibits moderate stability with a commendable equity ratio and manageable debt levels. However, the declining stockholders' equity and total assets over the recent periods indicate potential liquidity challenges. The company's debt-to-equity ratio remains low, mitigating financial risk to some extent.

Cash Flow

Cash flow analysis reveals a decline in operating cash flows and free cash flow generation over time. Despite recent positive free cash flow, the operating cash flow to net income ratio indicates struggles in converting earnings to cash. The volatility in cash flows suggests potential liquidity issues.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.19B	1.34B	2.02B	2.81B	1.68B	836.42M
Gross Profit	236.47M	274.25M	450.41M	627.69M	375.00M	202.73M
EBITDA	12.81M	3.99M	129.34M	285.14M	152.35M	2.41M
Net Income	-8.35M	-14.56M	72.63M	188.46M	132.00M	-12.14M
Balance Sheet
Total Assets	553.82M	589.25M	679.32M	947.84M	732.81M	356.97M
Cash, Cash Equivalents and Short-Term Investments	81.19M	81.63M	17.09M	3.60M	1.04M	1.60M
Total Debt	2.77M	3.87M	5.27M	157.75M	195.49M	73.15M
Total Liabilities	141.58M	170.29M	205.92M	490.62M	435.28M	202.06M
Stockholders Equity	412.24M	418.96M	473.39M	457.22M	297.53M	154.38M
Cash Flow
Free Cash Flow	34.09M	111.40M	234.52M	125.26M	-92.79M	22.59M
Operating Cash Flow	41.60M	120.12M	248.50M	134.05M	-85.62M	27.20M
Investing Cash Flow	-7.51M	-8.71M	-13.78M	-43.87M	-34.05M	-4.62M
Financing Cash Flow	-22.48M	-46.85M	-221.24M	-87.60M	119.09M	-22.01M

Cross Country Healthcare Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 13.23
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCRN, the sentiment is Negative. The current price of 13.23 is above the 20-day moving average (MA) of 13.22, above the 50-day MA of 13.15, and below the 200-day MA of 14.76, indicating a neutral trend. The MACD of 0.16 indicates Negative momentum. The RSI at 48.98 is Neutral, neither overbought nor oversold. The STOCH value of 64.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CCRN.

Cross Country Healthcare Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PNTG	71 Outperform	$838.82M	31.04	11.44%	―	30.58%	24.86%
HCSG	68 Neutral	$1.12B	109.33	2.28%	―	5.17%	-65.33%
AVAH	59 Neutral	$1.60B	101.99	42.49%	―	11.53%	―
AMN	56 Neutral	$779.90M	18.62	-40.13%	―	-14.33%	-398.68%
Sector *	51 Neutral	$7.83B	-0.15	-40.10%	2.29%	21.46%	-2.01%
CCRN	45 Neutral	$433.44M	―	-1.96%	―	-24.30%	-210.27%
MODV	41 Neutral	$8.29M	―	-951.52%	―	-0.70%	-2.38%

Cross Country Healthcare Corporate Events

Cross Country Healthcare Reports Q2 2025 Financial Results

Cross Country Healthcare announced its second quarter 2025 financial results, reporting a revenue of $274.1 million, a 19% decrease year-over-year. Despite a net loss of $6.7 million, the company highlighted strong performance in its Homecare and Physician Staffing segments, with a 30% revenue growth in Homecare Staffing and a 3% increase in Physician Staffing. The company maintains a healthy balance sheet with $81 million in cash and no debt, and it continues to invest in its operations while anticipating a merger with Aya Healthcare in the fourth quarter of 2025.

The most recent analyst rating on (CCRN) stock is a Hold with a $18.61 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.